We are live on ! Find out more
DNLI icon

Denali Therapeutics
DNLI

108 hedge funds and large institutions have $1.23B invested in Denali Therapeutics in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 38 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $1.24M | Put options by funds: $920K

13% more capital invested

Capital invested by funds: $1.09B → $1.23B (+$140M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.77% less ownership

Funds ownership: 74.56% → 73.79% (-0.77%)

8% less funds holding

Funds holding: 118 → 108 (-10)

21% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 38

26% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 19

Holders
108
Holders Change
-10
Holders Change %
-8.47%
% of All Funds
2.13%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
14
Increased
30
Reduced
38
Closed
19
Calls
$1.24M
Puts
$920K
Net Calls
+$323K
Net Calls Change
+$1.21M

Top Buyers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
+$9.99M
2
MWNA
Marshall Wace North America
New York
+$6.62M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$3.78M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.05M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.83M

Top Sellers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$15.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$13.2M
3
Millennium Management
Millennium Management
New York
-$1.56M
4
CEP
Chicago Equity Partners
Illinois
-$1.21M
5
First Trust Advisors
First Trust Advisors
Illinois
-$1.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$4.33M +$1.43M +85,709 +53%
Lord, Abbett & Co
27
Lord, Abbett & Co
New Jersey
$4.05M -$15.6M -937,242 -80%
Principal Financial Group
28
Principal Financial Group
Iowa
$3.92M +$102K +6,146 +3%
Invesco
29
Invesco
Georgia
$3.32M -$10.5K -629 -0.3%
N
30
Nuveen
North Carolina
$3.14M +$19.4K +1,163 +0.6%
Wells Fargo
31
Wells Fargo
California
$2.53M -$10.5K -631 -0.4%
EAM
32
Erste Asset Management
Austria
$2.5M – – –
Swiss National Bank
33
Swiss National Bank
Switzerland
$2.08M +$49.9K +3,000 +3%
Russell Investments Group
34
Russell Investments Group
United Kingdom
$2.04M +$796K +47,796 +69%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$1.89M +$331K +19,900 +22%
Goldman Sachs
36
Goldman Sachs
New York
$1.76M -$54.9K -3,300 -3%
Deutsche Bank
37
Deutsche Bank
Germany
$1.47M -$329K -19,784 -19%
JP Morgan Chase
38
JP Morgan Chase
New York
$1.35M +$1.03M +62,023 +395%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$1.27M -$33.7K -2,026 -3%
State of Wisconsin Investment Board
40
State of Wisconsin Investment Board
Wisconsin
$1.25M – – –
AllianceBernstein
41
AllianceBernstein
Tennessee
$1.24M – – –
MAM
42
Mark Asset Management
New York
$1.16M -$38.4K -2,307 -3%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$1.11M +$13K +782 +1%
UBS AM
44
UBS AM
Illinois
$1.01M -$33.6K -2,017 -3%
Citadel Advisors
45
Citadel Advisors
Florida
$933K -$580K -34,823 -39%
AQR Capital Management
46
AQR Capital Management
Connecticut
$857K -$329K -19,789 -29%
Barclays
47
Barclays
United Kingdom
$848K +$70.2K +4,218 +9%
Marshall Wace
48
Marshall Wace
United Kingdom
$808K +$772K +46,377 New
WG
49
Winton Group
United Kingdom
$792K +$757K +45,452 New
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$746K -$113K -6,800 -14%
1
2
3 4 5

DNLI Hedge Fund Activity: Q4 2019 in Review

108 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Denali Therapeutics (DNLI) for Q4 2019, worth a combined $1.23B — up 13% from $1.09B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of DNLI and 14 opened new positions — a net loss of 5 holders — while 38 trimmed existing stakes and 30 added.

The largest buyer was Casdin Capital, adding an estimated $9.99M. The largest seller was Lord, Abbett & Co, cutting an estimated $15.6M.

  • 108 institutional investors held Denali Therapeutics (DNLI) as of Q4 2019, down from 118 in Q3 2019.
  • Funds reported $1.23B of Denali Therapeutics stock for Q4 2019, up 13% quarter-over-quarter.
  • 14 funds opened new Denali Therapeutics positions in Q4 2019 and 19 closed out, a net change of -5 holders.
  • The largest Denali Therapeutics buyer in Q4 2019 was Casdin Capital, an estimated $9.99M added.
  • The largest Denali Therapeutics seller in Q4 2019 was Lord, Abbett & Co, an estimated $15.6M sold.

Based on aggregated 13F filings for Q4 2019.